Core Viewpoint - Yingke Medical (300677.SZ) plans to invest in Warburg Pincus Global Growth 15, L.P. through its wholly-owned subsidiary, Yingke Medical International (Hong Kong) Limited, committing $70 million as a limited partner in a fund targeting a total raise of $17 billion [1] Group 1 - Yingke Medical International will participate in the investment using its own funds [1] - The partnership aims to invest in sectors including healthcare, energy transition, business services, industrial, technology, consumer, and sustainable development [1] - The fund will focus on growth capital transactions, early-stage growth platforms, acquisitions, capital restructuring, and other special situations [1]

Core Viewpoint - Host Hotels & Resorts, Inc. advises holders of operating partnership units to reject an unsolicited mini-tender offer from MacKenzie Capital Management, which is priced significantly below the current market value of the company's common stock [1][2][3]. Group 1: Mini-Tender Offer Details - MacKenzie Capital Management made a mini-tender offer for up to 100,000 OP Units at a price of $10.55 per unit, which is below the market value [1]. - The offer follows multiple previous mini-tender offers by the Purchaser from 2016 to 2023 [1]. - The offer price is significantly lower than the closing stock price of $17.37 per share on September 24, 2025, indicating a substantial discount [2]. Group 2: Company Recommendations - The Company recommends that OP Unit holders reject the MacKenzie Offer due to its low price compared to the market value of the common stock [2][3]. - OP Unit holders can redeem their units for shares of common stock, which would have a market value of approximately $17.74 based on the recent closing price [2]. - The Company urges investors to consult financial and tax advisors and to be cautious regarding the unsolicited offer [3][4]. Group 3: Company Background - Host Hotels & Resorts, Inc. is the largest lodging real estate investment trust and owns 75 properties in the U.S. and five internationally, totaling approximately 42,900 rooms [5].

Financial Performance - GAAP net income attributable to Ares Management Corporation was $137.1 million[1] - After-tax realized income was $367.9 million, with after-tax realized income per share of Class A common stock at $1.03[2] - Fee related earnings reached $409.1 million[2] Assets Under Management (AUM) - Total AUM reached $572.4 billion, a 28% increase year-over-year[9, 32, 35] - Total fee paying AUM was $349.6 billion, a 27% increase year-over-year[23, 32, 35] - Available capital stood at $150.8 billion[3, 23, 46] - AUM not yet paying fees available for future deployment was $86.8 billion, potentially generating $822.7 million in incremental annual management fees[23, 49] Capital Activity - Gross new capital commitments totaled $26.2 billion[23, 31] - Capital deployment amounted to $26.9 billion, including $13.0 billion by drawdown funds[23, 61, 65] Dividends - A quarterly dividend of $1.12 per share was declared for Class A and non-voting common stock[4, 23] - A quarterly dividend of $0.84375 per share was declared for the 6.75% Series B mandatory convertible preferred stock[5, 23]

Core Insights - Manulife Investment Management successfully closed its third co-investment fund, raising $1.1 billion, surpassing its $750 million target and exceeding the previous fund by over $300 million [1][4]. Fundraising Strategy - The successful fundraising reflects the effectiveness of Manulife IM's co-investment strategy, which leverages the firm's established primary funds platform and extensive relationships with over 200 global sponsor partners [2]. - The strategy aims to provide institutional investors with direct access to high-quality private equity opportunities in middle market companies, supported by a disciplined investment team [2]. Investor Base - The fund attracted a diverse global investor base, including public and corporate pensions, insurance companies, asset managers, financial institutions, and family offices, with Manulife's General Account also committing capital [3]. Leadership Commentary - Vipon Ghai, global head of private equity and credit at Manulife IM, expressed gratitude for the support from both new and returning investors, highlighting their trust as crucial to the fund's success [4]. - Scott Garfield, senior managing director, emphasized the strength of the firm's consistent strategy and experienced team, which enables access to diversified private equity opportunities [5]. Asset Management Overview - Manulife IM's private equity and credit platform manages over $28 billion in assets, which includes primary funds, co-investments, secondaries, and various credit types, as part of a broader private markets platform [6][7].